India records highest single-day recoveries of Covid-19 cases; trials for Russia's 'Sputnik-V' vaccine soon


  • India
  • Tuesday, 22 Sep 2020

A health worker takes a nasal swab sample to test for COVID-19 test at a facility erected to screen people in Ahmedabad, India, Tuesday (Sept 22, 2020). The nation of 1.3 billion people is expected to become the coronavirus pandemic's worst-hit country within weeks, surpassing the United States. - AP

NEW DELHI, Sept. 22 (Xinhua): India's federal Ministry of Health on Tuesday said the country recorded highest single-day recoveries in the past 24 hours.

"In an unprecedented surge, India has recorded the highest number of single-day recoveries. More than 1 lakh (101,468) new recoveries have been registered in the last 24 hours in the country," the ministry said in a statement.

"In another landmark achievement, the trend of very high number of single-day recoveries has sustained for the past four consecutive days."

The ministry also said the "total number of recoveries are nearly 45 lakh".

"With this, the total number of recoveries are nearly 45 lakh (4,497,867). This has resulted in the recovery rate touching 80.86 per cent," the ministry said. "79 per cent of the new recovered cases are being reported from ten states, i.e., Maharashtra, Karnataka, Andhra Pradesh, Uttar Pradesh and Tamil Nadu, Odisha, Delhi, Kerala, West Bengal and Punjab."

The ministry said Maharashtra continues to lead with more than 31.5 percent of new recovered patients.

"The continuous streak of very high level of recoveries in the country is a testimony of the Centre-led proactive and graded strategy of -- test, track and treat. The effective clinical management and treatment protocols issued by the federal government have been updated from time to time with the emergence of new medical and scientific evidence," the ministry said.

According to ministry, India's low case fatality rate (CFR) currently stands at 1.59 percent.

Vendors sell bael leaves, used in hindu rituals, and streblus asper leaves, used for medicinal purposes, at Mullick Ghat on the banks of the Hoogly River in Kolkata, India, on Tuesday (Sept 22, 2020). India’s economic recovery prospects have gone from bad to worse after the nation emerged as a new global hotspot for the coronavirus pandemic with more than 5.5 million infections. - BloombergVendors sell bael leaves, used in hindu rituals, and streblus asper leaves, used for medicinal purposes, at Mullick Ghat on the banks of the Hoogly River in Kolkata, India, on Tuesday (Sept 22, 2020). India’s economic recovery prospects have gone from bad to worse after the nation emerged as a new global hotspot for the coronavirus pandemic with more than 5.5 million infections. - Bloomberg

Despite that, india, which has a population of more than 1.3 billion, is the world's second worst affected country by Covid-19 behind the United States.

For weeks, it has reported the world's highest daily jump in infections, which reached a total of 5.6 million on Tuesday.

Meanwhile, Reuters reported Dr Reddy's Laboratories Ltd could begin late-stage indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the indian drugmaker said on Tuesday.

indian trials of the Sputnik-V vaccine candidate, being developed by Russia's sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy's, told Reuters.

"We want to get to the first step - which is the commencement of the clinical trials by getting the necessary approvals from the indian regulators - within the next few weeks," Sapra said.

The trials are part of a deal between the Russian Direct Investment Fund (RDIF) and Dr Reddy's, in which the indian firm will conduct Phase III studies in india, pursue local regulatory approvals and, subject to approval, distribute the finished vaccine product in india. RDIF will supply 100 million doses to Dr Reddy's.

The RDIF has also reached agreements with indian manufacturers to produce 300 million doses of the shot in india. Russia was the first country to grant regulatory approval for a novel coronavirus vaccine.

Sputnik-V doses supplied in india will likely be a combination of indian- and Russian-made doses, Sapra said, adding that RDIF and Dr Reddy's would soon identify potential manufacturers in india.

The RDIF has said vaccine deliveries to india could begin in late 2020, but Sapra suggested it could take longer. "I think it's going to be several months before we accomplish all the steps in the process," he added.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

India , Recovery Rate , Covid-19 , Improving , Vaccine , Trials , Soon

   

Next In Aseanplus News

Search for missing Indonesian submarine finds oil spill
Cambodians can sell goods over new e-marketplace during lockdown
Asean News Headlines as at 8pm on Wednesday (April 21)
Seven crew rescued, four dead in Philippine ship grounding
Singapore to employ mix of coastal protection measures to guard against sea-level rise: experts
Vietnam PM to attend Asean summit on Myanmar
UN envoy to hold 'sideline' meetings ahead of Asean summit on Myanmar
Car sales surge 70 per cent in Indonesia after luxury tax cut
Singapore PM reaffirms ties with Vietnam in phone call to counterpart
Philippines boosts maritime presence to protect territory, resources

Stories You'll Enjoy


Vouchers